Publication
Article
Pharmaceutical Technology
Pharmaceutical Technology-06-02-2003Volume27 Issue 6
From Genome Exploration to Drug Development
Author(s):
FDA's plan to establish pharmacogenomic policies spurs concerns among manufacturers, particularly in regard to how the policies will affect new-drug testing and approval.
Articles in this issue
June 2003
From Genome Exploration to Drug Development
Are you ready for Gen3
Enhancement of the Dissolution Rate and Bioavailability of Glipizide through Cyclodextrin Inclusion Complex
Formulation Development of a Nucleotide Phosphoramidate
Behavior of Uptake of Moisture by Drugs and Excipients under Accelerated Conditions of Temperature and Humidity in the Absence and the Presence of Light
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
